Broadview Ventures
Broadview Ventures, based in Boston, MA, is dedicated to accelerating the development of innovative technologies aimed at diagnosing and treating cardiovascular diseases and stroke through targeted investments. Their diversified portfolio includes various companies developing groundbreaking solutions, from anticoagulants to AI-driven monitoring devices.
Portfolio highlights feature clinical-stage firms like Alveron Pharmaceuticals, which is creating a novel anticoagulant reversal agent, and Cardiosense, focused on a physiological waveform AI platform for cardiovascular disease management. Other noteworthy companies include Comanche Biopharma, addressing preeclampsia treatment, and Nyra Medical, which develops innovative devices for mitral regurgitation.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.